Disclaimer: This site aggregates publicly available data from official government sources (FDA, ClinicalTrials.gov, PubMed, SEC EDGAR) for general reference only. It does NOT constitute medical advice, diagnosis, treatment recommendations, or investment advice.

FDA 510(k)

Comby EEG Caps

K-Number: K211315 · 2021-11-09

ApplicantPamel D.O.O
Decision Date2021-11-09
Product CodeGXY
Advisory CommitteeNE
DecisionSubstantially Equivalent

Device Summary

Comby EEG Caps is the device name listed in this FDA 510(k) record. The listed applicant is Pamel D.O.O. It received FDA 510(k) clearance on 2021-11-09 under 510(k) number K211315. The device is classified under product code GXY. It was reviewed by the NE advisory panel. FDA Decision: Substantially Equivalent.

Frequently Asked Questions

What is the Comby EEG Caps?

Comby EEG Caps is a medical device that received FDA 510(k) clearance on 2021-11-09. The listed applicant is Pamel D.O.O. The 510(k) number is K211315.

When did Comby EEG Caps receive FDA 510(k) clearance?

Comby EEG Caps received FDA 510(k) clearance on 2021-11-09, under 510(k) number K211315.

Who is the listed applicant for Comby EEG Caps?

The FDA 510(k) record lists Pamel D.O.O as the applicant. This does not by itself establish the device manufacturer.

What is the FDA product code for Comby EEG Caps?

The FDA product code for Comby EEG Caps is GXY.

Related Devices (Code: GXY)

Related records are matched automatically using names, product codes, or other metadata. A match does not establish a verified clinical, scientific, corporate, or regulatory relationship; review the linked official sources.

Official Source

View on FDA Database →

Data sourced from FDA Open API. For the most current and authoritative information, always refer to the official record.